Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

The novel prostate cancer antigen 3 (PCA3) biomarker.

Bourdoumis A, Papatsoris AG, Chrisofos M, Efstathiou E, Skolarikos A, Deliveliotis C.

Int Braz J Urol. 2010 Nov-Dec;36(6):665-8; discussion 669. Review.

2.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Review.

PMID:
21871709
3.

PCA3: from basic molecular science to the clinical lab.

Day JR, Jost M, Reynolds MA, Groskopf J, Rittenhouse H.

Cancer Lett. 2011 Feb 1;301(1):1-6. doi: 10.1016/j.canlet.2010.10.019. Epub 2010 Nov 18. Review.

PMID:
21093148
4.

The Prostate Cancer gene 3 assay: indications for use in clinical practice.

Schilling D, de Reijke T, Tombal B, de la Taille A, Hennenlotter J, Stenzl A.

BJU Int. 2010 Feb;105(4):452-5. doi: 10.1111/j.1464-410X.2009.09085.x. Epub 2009 Nov 20. Review.

5.

[Value of urinary PCA3 test for prostate cancer diagnosis].

Vlaeminck-Guillem V, Ruffion A, Andre J.

Prog Urol. 2008 May;18(5):259-65. doi: 10.1016/j.purol.2008.03.029. Epub 2008 May 16. Review. French.

PMID:
18538269
6.

Contemporary role of prostate cancer gene 3 in the management of prostate cancer.

Roobol MJ.

Curr Opin Urol. 2011 May;21(3):225-9. doi: 10.1097/MOU.0b013e328344939c. Review.

PMID:
21301341
7.

Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.

Salagierski M, Schalken JA.

J Urol. 2012 Mar;187(3):795-801. doi: 10.1016/j.juro.2011.10.133. Epub 2012 Jan 15. Review.

PMID:
22245323
8.

The use of PCA3 in the diagnosis of prostate cancer.

Hessels D, Schalken JA.

Nat Rev Urol. 2009 May;6(5):255-61. doi: 10.1038/nrurol.2009.40. Review.

PMID:
19424173
9.

Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects.

Schmid M, Hansen J, Chun FK.

Adv Exp Med Biol. 2015;867:277-89. doi: 10.1007/978-94-017-7215-0_17. Review.

PMID:
26530372
10.

Urinary prostate cancer 3 test: toward the age of reason?

Vlaeminck-Guillem V, Ruffion A, André J, Devonec M, Paparel P.

Urology. 2010 Feb;75(2):447-53. doi: 10.1016/j.urology.2009.03.046. Epub 2009 Jul 8. Review.

PMID:
19586654
11.

[The search for better markers for prostate cancer than prostate-specific antigen].

Schenk-Braat EA, Bangma CH.

Ned Tijdschr Geneeskd. 2006 Jun 10;150(23):1286-90. Review. Dutch.

PMID:
16821452
12.

New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.

Schalken JA, Hessels D, Verhaegh G.

Urology. 2003 Nov;62(5 Suppl 1):34-43. Review.

PMID:
14607216
13.

UPM3: review of a new molecular diagnostic urine test for prostate cancer.

Saad F.

Can J Urol. 2005 Feb;12 Suppl 1:40-3; discussion 99-100. Review.

PMID:
15780164
14.

Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.

Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N.

J Urol. 2013 Aug;190(2):389-98. doi: 10.1016/j.juro.2013.02.005. Epub 2013 Mar 29. Review.

PMID:
23545099
15.

Optimising repeat prostate biopsy decisions and procedures.

Kirby R, Fitzpatrick JM.

BJU Int. 2012 Jun;109(12):1750-4. doi: 10.1111/j.1464-410X.2011.10809.x. Epub 2011 Dec 22. Review.

16.

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).

Kirby RS, Fitzpatrick JM, Irani J.

BJU Int. 2009 Feb;103(4):441-5. doi: 10.1111/j.1464-410X.2008.08280.x. Epub 2009 Jan 9. Review.

17.
18.

Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2014 Apr;16(4):338-46. doi: 10.1038/gim.2013.141. Epub 2013 Sep 26. Review.

PMID:
24071797
19.

Current biomarkers for diagnosing of prostate cancer.

Stephan C, Jung K, Ralla B.

Future Oncol. 2015;11(20):2743-55. doi: 10.2217/fon.15.203. Epub 2015 Sep 11. Review.

PMID:
26358139
20.

Prostate-specific antigen.

Ornstein DK, Pruthi RS.

Expert Opin Pharmacother. 2000 Dec;1(7):1399-411. Review.

PMID:
11249473

Supplemental Content

Support Center